Advanced search
Publication Cover
The Neurodiagnostic Journal Volume 58, 2018 - Issue 2
Submit an article Journal homepage
1,207
Views
0
CrossRef citations to date
0
Altmetric
Articles

Novel Therapies for Sleep Apnea—The Implants Have Arrived!

Edwin M. ValladaresUSC Sleep Disorders Center, Keck Medical Center of USC, University of Southern California, Los Angeles, California;Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Keck School of Medicine of USC, Los Angeles, California;USC Center for Sleep Health Using Bioengineering, USC Viterbi School of Engineering, University of Southern California, Los Angeles, CaliforniaCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-3067-276X
, MS, RPSGT, RST ORCID Icon &
Terese C. HammondUSC Sleep Disorders Center, Keck Medical Center of USC, University of Southern California, Los Angeles, California;Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Keck School of Medicine of USC, Los Angeles, California;USC Center for Sleep Health Using Bioengineering, USC Viterbi School of Engineering, University of Southern California, Los Angeles, California
, M.D.
Pages 116-125 | Received 16 Nov 2017, Accepted 09 May 2018, Published online: 20 Jun 2018
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

ABSTRACT

Positive airway pressure (PAP) therapy has been the standard treatment of choice for sleep disordered breathing, with 29–83% of patients being noncompliant. With the advent of newly Food and Drug Adminisatration (FDA)-approved implantable stimulators for treating sleep disordered breathing in a fraction of noncompliant PAP therapy patients, the landscape of sleep medicine and sleep technology is changing to narrow the gap between compliant and non-compliant patients. The remedē® System for treating central sleep apnea and the Inspire® upper airway stimulation (UAS) therapy for treating obstructive sleep apnea are providing new tools for sleep physicians, elevating sleep technologists’ expertise, and paving the way for personalized medicine.

DISCLOSURE STATEMENT

EMV consulted for ReVENT Medical, Inc., and Nyxoah S.A.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 53.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 164.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.